Confirmatory and Quantitative Analysis of β-Lactam Antibiotics in Bovine Kidney Tissue by Dispersive Solid-Phase Extraction and Liquid Chromatography-Tandem Mass Spectrometry by Fagerquist, Clifton K. et al.
University of Nebraska - Lincoln 
DigitalCommons@University of Nebraska - Lincoln 
Publications from USDA-ARS / UNL Faculty U.S. Department of Agriculture: Agricultural Research Service, Lincoln, Nebraska 
3-1-2005 
Confirmatory and Quantitative Analysis of β-Lactam Antibiotics in 
Bovine Kidney Tissue by Dispersive Solid-Phase Extraction and 
Liquid Chromatography-Tandem Mass Spectrometry 
Clifton K. Fagerquist 
USDA-ARS, cfagerquist@pw.usda.gov 
Alan R. Lightfield 
USDA-ARS, alan.lightfield@ars.usda.gov 
Steven J. Lehotay 
USDA-ARS, Steven.Lehotay@ars.usda.gov 
Follow this and additional works at: https://digitalcommons.unl.edu/usdaarsfacpub 
Fagerquist, Clifton K.; Lightfield, Alan R.; and Lehotay, Steven J., "Confirmatory and Quantitative Analysis 
of β-Lactam Antibiotics in Bovine Kidney Tissue by Dispersive Solid-Phase Extraction and Liquid 
Chromatography-Tandem Mass Spectrometry" (2005). Publications from USDA-ARS / UNL Faculty. 1763. 
https://digitalcommons.unl.edu/usdaarsfacpub/1763 
This Article is brought to you for free and open access by the U.S. Department of Agriculture: Agricultural Research 
Service, Lincoln, Nebraska at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in 
Publications from USDA-ARS / UNL Faculty by an authorized administrator of DigitalCommons@University of 
Nebraska - Lincoln. 
Confirmatory and Quantitative Analysis of
â-Lactam Antibiotics in Bovine Kidney Tissue by
Dispersive Solid-Phase Extraction and Liquid
Chromatography-Tandem Mass Spectrometry
Clifton K. Fagerquist,*,† Alan R. Lightfield,‡ and Steven J. Lehotay‡
Western Regional Research Center, Agricultural Research Service, U.S. Department of Agriculture,
Albany, California 94710, and Eastern Regional Research Center, Agricultural Research Service,
U.S. Department of Agriculture, Wyndmoor, Pennsylvania 19038
A simple, rapid, rugged, sensitive, and specific method
for the confirmation and quantitation of 10 â-lactam
antibiotics in fortified and incurred bovine kidney tissue
has been developed. The method uses a simple solvent
extraction, dispersive solid-phase extraction (dispersive-
SPE) cleanup, and liquid chromatography-tandem mass
spectrometry (LC/MS/MS) for confirmation and quanti-
tation. Dispersive-SPE greatly simplifies and accelerates
sample cleanup and improves overall recoveries com-
pared with conventional SPE cleanup. The â-lactam
antibiotics tested were as follows: deacetylcephapirin (an
antimicrobial metabolite of cephapirin), amoxicillin, des-
furoylceftiofur cysteine disulfide (DCCD, an antimicrobial
metabolite of ceftiofur), ampicillin, cefazolin, penicillin G,
oxacillin, cloxacillin, naficillin, and dicloxacillin. Average
recoveries of fortified samples were 70% or better for all
â-lactams except DCCD, which had an average recovery
of 58%. The LC/MS/MS method was able to demonstrate
quantitative recoveries at established tolerance levels and
provide confirmatory data for unambiguous analyte iden-
tification. The method was also tested on 30 incurred
bovine kidney samples obtained from the USDA Food
Safety and Inspection Service, which had previously tested
the samples using the approved semiquantitative micro-
bial assay. The results from the quantitative LC/MS/MS
analysis were in general agreement with the microbial
assay for 23 samples although the LC/MS/MS method
was superior in that it could specifically identify which
â-lactam was present and quantitate its concentration,
whereas the microbial assay could only identify the type
of â-lactam present and report a concentration with
respect to the microbial inhibition of a penicillin G
standard. In addition, for 6 of the 23 samples, LC/MS/
MS analysis detected a penicillin and a cephalosporin
â-lactam, whereas the microbial assay detected only a
penicillin â-lactam. For samples that do not fall into the
“general agreement” category, the most serious discrep-
ancy involves two samples where the LC/MS/MS method
detected a violative level of a cephalosporin â-lactam
(deacetylcephapirin) in the first sample and a possibly
violative level of desfuroylceftiofur in the second, whereas
the microbial assay identified the two samples as having
only violative levels of a penicillin â-lactam.
Antibiotics are widely used at therapeutic levels, in humans
as well as animals, for the treatment of bacterial infections.
However, the use of subtherapeutic levels of antibiotics in food-
producing animals to increase bulk may lead to the emergence
of antibiotic-resistant bacterial strains. In addition, antibiotic
residues in milk or edible tissues are potential risks for individuals
who are hypersensitive to antibiotics. In consequence, the dual
use of antibiotics has become an increasingly important public
health concern. Antibiotics approved for use in food-producing
animals have established tolerances for detection of their residues
in milk, kidney, muscle, and liver. Detection of these residues
above the established tolerance level constitutes a violation.
Numerous methods exist to detect and quantify antibiotic residues
in milk and edible tissues; however, efforts to improve (or even
replace) existing methods remain an active area of research.
Methods to detect and quantify antibiotics range from single-
analyte to multiresidue or multiclass methods. Single-analyte
detection has the advantage that the method can be optimized
for maximum recovery of a single analyte in a specific matrix.
Single-analyte methods are highly favored by the pharmaceutical
industry due to the regulatory approval process of any new drug.
In contrast, multiresidue methods are designed to maximize the
number of analytes detected within a particular class while
recovery optimization remains an important but secondary issue.
Multiclass methods are even more ambitious in their goal of
maximizing the number of analytes detected among two of more
drug classes. The more chemically dissimilar a group of analytes,
the greater the difficulty of finding a single method that extracts
and detects all the analytes in all matrixes with acceptable
recoveries. Typically, multiresidue method development involves
selecting compounds for analysis that are chemically similar. The
more chemically similar a group of analytes, the more likely that
a single method will be successful for detection of all analytes in
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a particular matrix. Multiresidue (and multiclass) methods are
favored by regulatory agencies as part of their mandate to monitor
the food supply for a variety of regulated drugs and other chemical
compounds.
One of the most widely used class of antibiotics are the
â-lactams, which include penicillins and cephalosporins. Numerous
methods have been developed for both single-analyte and multi-
residue analysis of â-lactam antibiotics in milk and edible
tissues.1-20 These methods range from single-analyte extraction
and cleanup with liquid chromatography-ultraviolet detection
(LC/UV) to multiresidue methods, which commonly use either
liquid chromatography-mass spectrometry (LC/MS) or tandem
mass spectrometry (LC/MS/MS). For example, Hornish et al.19
recently reported the multilaboratory trial of a single-analyte
method to detect the total residues of ceftiofur by LC/UV.
Ceftiofur is a cephalosporin â-lactam that upon intramuscular
injection rapidly converts to the antimicrobial metabolite desfu-
roylceftiofur (DFC), which has a free thiol group. DFC binds
reversibly to cysteine residues in peptides and proteins through
disulfide bonds. The method devised by Hornish et al. involves
reduction of all disulfide bonds in a sample thus releasing all
bound DFC followed by acetylation of the DFC thiol group.19
Separation and detection of the acetylated DFC is then performed
by LC/UV. Although such a method is excellent for measuring
total residues of ceftiofur, it is not compatible with multiresidue
analysis because the reduction and acetylation steps may result
in chemical degradation of other â-lactam antibiotics present in a
sample.
In a recent study, Fagerquist and Lightfield20 demonstrated
confirmatory analysis of 11 â-lactam antibiotics in bovine kidney
tissue using solvent extraction followed by conventional solid-
phase extraction (SPE) cleanup with confirmation by LC/MS/
MS analysis. In that study, LC/MS/MS was performed using a
quadrupole ion trap mass spectrometer with an electrospray
ionization (ESI) source. Although confirmatory analysis was
achieved at tolerance levels for most of the analytes, quantitation
was not successful due to a lack of linearity and reproducibility
of calibration curves. The lack of linearity and reproducibility was
possibly caused by the following: (1) ion source limitations; (2)
suppression of analyte ionization by coeluting matrix contaminants;
(3) competitive exclusion of analyte ions in the mass analyzer by
more abundant matrix ions. Further experiments with this sample
preparation method using a recently acquired triple quadrupole
mass spectrometer produced dramatically improved results with
respect to sensitivity, linearity, and reproducibility thus making
quantitation possible.
In the current study, we report results obtained with instru-
mentation more appropriate to residue analysis in complex
matrixes. In addition, we report a significant improvement in
sample cleanup by replacing conventional SPE cleanup with
dispersive solid-phase extraction (dispersive-SPE), a technique that
greatly simplifies and accelerates sample cleanup.21 Confirmation
and quantitation of fortified bovine kidney samples was performed
using the new method at concentration levels of 5-1000 ng/g.
We also report confirmation and quantitation results for 30
incurred bovine kidney samples that were previously analyzed
using a semiquantitative microbial assay.
EXPERIMENTAL SECTION
Antibiotic Standards. Eleven â-lactam antibiotics were used
in the present study: deacetylcephapirin (DECEPH), amoxicillin
(AMOX), desfuroylceftiofur cysteine disulfide (DCCD), ampicillin
(AMP), cefazolin (CFZN), penicillin G (PEN G), penicillin V (PEN
V) used as an internal standard, oxacillin (OX), cloxacillin (CLOX),
naficillin (NAF), and dicloxacillin (DICLOX). DECEPH was
generously provided by the Food and Drug Adminstration (FDA)
Center for Veterinary Medicine (Laurel, MD). AMOX, AMP,
CFZN, PEN G, PEN V, CLOX, and NAF were obtained from U.S.
Pharmacopeia (Rockville, MD). OX and DICLOX were obtained
from Sigma (St. Louis, MO). DCCD was generously provided by
Pharmacia, Animal Health Preclinical Development (Kalamazoo,
MI). Individual stock solutions of each â-lactam were prepared at
a concentration of 100 íg/mL in 50:50 methanol/water and stored
in amber-colored bottles at -20 °C. From the individual stock
solutions, a mixed stock solution was prepared at a concentration
of 10 íg/mL per analyte. Tenfold serial dilutions of the 10 íg/
mL mixed stock in methanol/water produced additional mixed
stock solutions at concentrations of 1.0 íg/mL per analyte and
0.1 íg/mL per analyte. These mixed stock solutions were used
to spike control tissue samples at concentrations ranging from 5
to 1000 ng/g and prepare matrix-matched standards (MMS) at
concentrations ranging from 1 to 1000 ng/g for calibration curves.
Individual and mixed stock solutions were replaced once a month.
MMS and fortified samples (or incurred) were spiked with the
same amount of internal standard (PEN V) on the day of the
analysis at a concentration of either 500 or 250 ng/g.
Sample Preparation: Overview. Incurred bovine kidney
tissue samples were provided by the USDA Food Safety and
Inspection Service (FSIS, St. Louis, MO) and stored in a -80 °C
(1) Voyksner, R. D.; Tyczkowska, K. L.; Aronson, A. L. J. Chromatogr., B 1991,
567, 389-404.
(2) Moats, W. A. J. Chromatgr. 1992, 593, 15-20.
(3) Blanchflower, W. J.; Hewitt, S. A.; Kennedy, D. G. Analyst 1994, 119, 2595-
2601.
(4) Moats, W. A. J. AOAC Int. 1994, 77, 41-45.
(5) Moats, W. A.; Harik-Khan R. J. AOAC Int. 1995, 78, 49-54.
(6) Moats, W. A.; Romanowski, R. D. J. Chromatogr., A 1998, 812, 237-247.
(7) Moats, W. A.; Romanowski, R. D. J. Agric. Food Chem. 1998, 46, 1410-
1413.
(8) Moats, W. A.; Romanowski, R. D.; Medina, M. B. J. AOAC Int. 1998, 81,
1135-1140.
(9) Keever, J.; Voyksner, R. D.; Tyczkowska, K. L. J. Chromatogr., A 1998,
794, 57-62.
(10) Schermerhorn, P. G.; Chu, P. S.; Ngoh, M. A. J. AOAC Int. 1998, 81, 973-
977.
(11) Heller, D. N.; Ngoh, M. A. Rapid Commun. Mass Spectrom. 1998, 12, 2031-
2040.
(12) Daeseleire, E.; De Ruyck H.; van Renterghem, R. Rapid Commun. Mass
Spectrom. 2000, 14, 1404-1409.
(13) Riediker, S.; Stadler, R. H. Anal. Chem. 2001, 73, 1614-1621.
(14) Riediker, S.; Diserens, J. M.; Stadler, R. H. J. Agric. Food Chem. 2001, 49,
4171-4176.
(15) Bruno, F.; Curini, R.; Di Corcia, A.; Nazzari, M.; Samperi, R. J. Agric. Food
Chem. 2001, 49, 3463-3470.
(16) Holstege, D. M.; Puschner, B.; Whitehead, G.; Galey, F. D. J. Agric. Food
Chem. 2002, 50, 406-411.
(17) Ito, Y.; Ikai, Y.; Oka, H.; Matsumoto, H.; Miyazaki, Y.; Takeba, K.; Nagase,
H. J. Chromatogr., A 2001, 911, 217-223.
(18) De Baere, S.; Cherlet, M.; Baert, K.; De Backer, P. Anal. Chem. 2002, 74,
1393-1401.
(19) Hornish, R. E.; Hamlow, P.; Brown, S. J. AOAC Int. 2003, 86: 30-38.
(20) Fagerquist, C. K.; Lightfield, A. R. Rapid Commun. Mass Spectrom. 2003,
17, 660-671.
(21) Anastassiades, M.; Lehotay, S. J.; Sÿ tajnbaher, D.; Schenck, F. J. J. AOAC
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freezer upon arrival to our laboratory. Several 1.0-g portions of
the kidney sample were analyzed. In order that the selected
portions were representative of the whole sample, each sample
was homogenized to a semisolid/semiliquid consistency using a
RS1 2Y1 Robot Coupe food processor (Robot Coupe USA Inc.,
Ridgeland, MS). Fatty connective tissue was removed prior to
homogenization. After homogenization, the sample was transferred
to small plastic bags, labeled, and restored in the -80 °C freezer.
Approximately 3-4 h after storage, the sample was prepared (in
duplicate) by the method described below and analyzed by LC/
MS/MS to determine which, if any, analytes were present and to
obtain an approximate estimate of their concentrations. No internal
standard was added during this initial screening process. The
following day, MMS were prepared at an appropriate concentration
range using control kidney tissue. The incurred samples were
prepared again in duplicate, as before, and MMS and incurred
samples were analyzed by LC/MS/MS. PEN V was used as an
internal standard in both incurred samples and MMS to correct
for intersample instrument variability. The MMS were used to
generate a calibration curve from which concentrations of incurred
samples were calculated by interpolation. Separate experiments
were conducted to determine the percent recovery of each analyte
using this method by analyzing fortified control kidney samples.
The percent recoveries were then used to calculate the actual
concentrations of analytes in incurred tissue kidney samples.
Sample Preparation. Kidney tissue samples were prepared
using a method similar to that described previously by Fagerquist
and Lightfield.20 However, an important modification has been
made to simplify and accelerate sample cleanup, which also
improved overall analyte recovery, i.e., dispersive-SPE.21 Incurred
tissue samples were prepared as follows. A 1.0-g portion of frozen,
homogenized beef kidney tissue was deposited into a 50-mL
polypropylene centrifuge tube (Corning). Unused sample was re-
stored at -80 °C. The sample was allowed to thaw to room
temperature after which 2.0 mL of water and 8.0 mL of acetonitrile
(MeCN) were added. The capped tube was vortexed briefly and
then placed on a free-standing vortex mixer for 5.0 min. The
sample tube was then centrifuged at 4500 rpm (2790 g), 4 °C for
5.0 min using a fixed-angle rotorhead A500 on a Sorvall RT 6000
B refrigerated centrifuge (Dupont). After centrifugation, a solid
pellet of protein material formed at the bottom of the tube. The
ratio of 1 g of tissue to 2 mL of water and 8 mL of MeCN was
found to be optimal for antibiotic extraction/sample deprotein-
ization.7,20 Approximately 10 mL of supernatant was decanted into
a 15-mL polypropylene tube (Corning), which contained 0.5 g of
Bakerbond C18 sorbent, 40-ím particle size (J. T. Baker, Phillips-
burg, NJ). The tube was then capped and inverted several times
by hand until the sorbent material dispersed thoroughly with the
extract. This constitutes the dispersive-SPE cleanup step. The
simplicity of this technique contrasts favorably with the more
laborious conventional SPE cleanup that requires column condi-
tioning, gravitational loading, and elution of sample, as well as
the need for a SPE cartridge manifold.20 After the dispersive-SPE
step, the tube was then centrifuged at 4500 rpm (2750 g) at 4 °C
for 5.0 min using a fixed-angle rotorhead A384, which resulted in
the sorbent material being deposited at the bottom of the tube.
Approximately 10 mL of supernatant was transferred using a
disposable pipet to a 20  150 mm disposable glass cultured tube
(VWR Scientific Products) with minimal carryover of sorbent. The
tube was then placed in a TurboVap LV evaporator (Zymark,
Hopkinton, MA) set at 38-40 °C with maximum nitrogen flow.
Extraction solvents were evaporated to a final aqueous volume of
1.0-1.3 mL, which took 30-40 min. The extract was then
transferred by disposable pipet to a Luer-lock 5.0-mL glass syringe
(Micro-Mate, Popper & Sons, Inc., New York, NY) fitted with a
0.2-ím polyethersulfone syringe filter (Whatman, Puradisc, 25 AS,
Clifton, NJ). The sample was syringe filtered directly into a glass
HPLC autosampler vial. A fixed amount of internal standard (PEN
V) was added to the vial. If necessary, water was added to bring
the final volume to 1.5 mL.
Analyte recoveries were determined from fortification experi-
ments replicated over three separate days. Kidney tissue was
obtained from a local supermarket, homogenized, extracted,
cleaned up, analyzed by LC/MS/MS, and found to be free of the
11 antibiotics used in this study and thus suitable for use as control
tissue for fortified experiments. Homogenized control tissue was
allowed to thaw to room temperature prior to fortification of 1.0-g
portions. Fortification concentrations were 5, 10, 25, 50, 100, 250,
500, and 1000 ng/g. After fortification, the samples were vortexed/
mixed for 10-15 s followed by a pause of 5.0 min before addition
of the extraction/deproteinization solvents (8 mL of MeCN + 2
mL of water). The reason for this “pause” was to reproduce, as
closely as possible, the conditions under which analytes in
incurred samples were exposed to homogenized tissue. Upon
addition of the extraction solvents, the fortified samples were
processed identically to the incurred samples.
MMS were prepared and analyzed concurrently with fortified
and incurred samples in order to accurately measure their
concentrations. MMS correct for matrix suppression (or enhance-
Table 1. HPLC Chromatographic Conditionsa
mobile phasetime
(min)
flow rate
(mL/min) A (%) B (%)
0.0 0.30 100 0.0
22.0 0.30 0.0 100
22.1 0.50 0.0 100
27.0 0.50 0.0 100
28.0 0.50 100 0.0
31.0 0.50 100 0.0
31.1 0.30 100 0.0
33.0 0.30 100 0.0
a Mobile phase A, 0.1% formic acid; mobile phase B, 50% methanol,
50% acetonitrile, 0.1% formic. Divert valve: 0.0-8.0 min (waste), 8.0-
24.0 min (MS), 24.0-33.0 min (waste).
Table 2. Mass Spectrometry Instrument Parameters
Common to All Analytes
nebulizer gas (NEB) 12.0 (au)
curtain gas (CUR) 10.0 (au)
auxiliary gas (AUX) 6000 mL/min
collision gas setting (CAD) 12.0 (au)
source temperature (TEM) 550 °C
entrance potential (EP) 10.0 V
multiplier deflector (DF) -400 V
multiplier voltage (CEM) 2200 or 2400 V
resolution Q1 unit
ion energy 0.60 or 0.70 V
resolution Q3 Unit
ion energy 0.70 or -0.50 V
MRM dwell time 50 ms
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ment) effects during analyte ionization. MM extract was generated
from 1.0-g portions of control tissue that was processed identically
to that of incurred tissue. Antibiotic standards were added directly
to the autosampler vials at concentrations of 0, 1, 5, 10, 25, 50,
100, 250, 500, and 1000 ng/g (or higher if incurred sample
concentrations required it). If necessary, water was added to adjust
the final volume of the MMS to 1.5 mL.
Liquid Chromatography/Tandem Mass Spectrometry.
Samples were analyzed by LC/MS/MS using a high-performance
liquid chromatograph (1100 LC binary pump, Agilent) interfaced
to a triple quadrupole mass spectrometer (API 3000, Applied
Biosystems/MDS Sciex, Toronto, ON, Canada). Sample injection
volume was 100 íL using an Agilent 1100 autosampler. Chro-
matographic separation was performed with a YMC ODS-AQ
column (Waters, 4.6  50 mm, particle size 3 ím; pore size 120
Å). LC was used to chromatographically separate matrix contami-
nants and analytes. No column heater was used. Early-eluting
matrix contaminants were diverted to waste using a Valco divert
valve. The timing of LC gradients and valve positions are given
in Table 1. An LC flow rate of 0.300 mL/min was found to be
Table 3. Ion Source and Analyzer Parameters: Collision Energy (CE), Collision Exit Potential (CXP), Ion Source
Voltage (IS), Declustering Potential (DP), and Focusing Potential (FP)
analyte
transition
(m/z)
CE
(V)
CXP
(V)
IS
(V)
DP
(V)
FP
(V)
period
(min)
DECEPH 382.0 f 112.0 35.0 10.0 5000 36.0 130 0.0-11.2
382.0 f 152.0 37.0 14.0 5000 36.0 130 0.0-11.2
382.0 f 226.0 27.0 10.0 5000 36.0 130 0.0-11.2
382.0 f 292.0 21.0 22.0 5000 36.0 130 0.0-11.2
AMOX 366.0 f 349.0 13.0 10.0 5000 21.0 90 0.0-11.2
366.0 f 114.0 27.0 8.0 5000 21.0 90 0.0-11.2
366.0 f 208.0 19.0 14.0 5000 21.0 90 0.0-11.2
DCCD 549.0 f 241.0 29.0 16.0 5500 41.0 160 11.2-12.7
549.0 f 366.0 31.0 10.0 5500 41.0 160 11.2-12.7
549.0 f 397.0 27.0 12.0 5500 41.0 160 11.2-12.7
AMP 350.0 f 192.0 19.0 18.0 5000 26.0 110 12.7-14.2
350.0 f 106.0 23.0 6.0 5000 26.0 110 12.7-14.2
350.0 f 160.0 23.0 28.0 5000 26.0 110 12.7-14.2
350.0 f 174.0 23.0 10.0 5000 26.0 110 12.7-14.2
CFZN 455.0 f 323.0 17.0 10.0 5000 31.0 130 14.2-19.7
455.0 f 156.0 23.0 13.0 5000 31.0 130 14.2-19.7
PEN G 335.0 f 160.0 17.0 10.0 5000 36.0 140 19.7-20.95
335.0 f 176.0 19.0 12.0 5000 36.0 140 19.7-20.95
PEN V (IS) 351.0 f 160.0 17.0 10.0 5000 31.0 130 20.95-21.85
351.0 f 192.0 15.0 8.0 5000 31.0 130 20.95-21.85
OXA 402.0 f 160.0 19.0 10.0 5000 31.0 140 20.95-21.85
402.0 f 243.0 19.0 18.0 5000 31.0 140 20.95-21.85
CLOX 436.0 f 160.0 21.0 10.0 5000 31.0 130 21.85-24.0
436.0 f 277.0 19.0 20.0 5000 31.0 130 21.85-24.0
438.0 f 279.0 19.0 20.0 5000 31.0 130 21.85-24.0
NAF 415.0 f 199.0 19.0 14.0 5000 26.0 100 21.85-24.0
415.0 f 256.0 23.0 18.0 5000 26.0 100 21.85-24.0
DICLOX 470.0 f 160.0 21.0 10.0 5000 36.0 160 21.85-24.0
470.0 f 311.0 21.0 22.0 5000 36.0 160 21.85-24.0
472.0 f 313.0 21.0 22.0 5000 36.0 160 21.85-24.0
Figure 1. Total ion LC/MS/MS of a MMS at a concentration of 250 ng/g. Vertical bars delineate preset acquisition windows.
1476 Analytical Chemistry, Vol. 77, No. 5, March 1, 2005
optimal for baseline separation of analytes as well as efficient ESI.
Samples were ionized in positive ESI mode using Turboionspray
(MDS Sciex).
Table 2 summarizes mass spectrometry parameters that were
common to the analysis of all 11 â-lactam antibiotics. MS/MS
analysis was performed in MRM mode, which monitored two to
four of the most abundant precursor f fragment ion transitions
of each analyte. An extracted ion chromatogram (XIC) was
generated for each precursor f fragment ion transition. The XIC
peak was integrated, and its area was summed to the areas of the
other XIC transitions of a particular analyte. This total integrated
area was used for quantitation of each particular analyte. The ratio
of the XIC integrated areas of the two most abundant and
structurally significant transitions of an analyte were used for
confirmation. Given the total number of transitions, i.e., 30, and
the necessity to obtain a sufficient number of data points across
a chromatographic peak, it was not possible (or necessary) to
monitor all the transitions of all the analytes for the entire
chromatographic cycle. Instead, MRM experiments were grouped
to monitor the transitions of particular analytes during a prespeci-
fied elution window. Table 3 summarizes the analyte transitions
and their associated instrument parameters.
Data Analysis: Confirmation and Quantitation. Calibration
curves of MMS were fitted to a first- or second-order polynomial
using a graphing/mathematical analysis software program Origin,
version 7.0 (OriginLab, Northampton, MA). Consistent with
analyte ionization by ESI, a 1/x weighting was used. The
concentrations of incurred and fortified samples were interpolated
(or occasionally extrapolated) from the MMS calibration curves.
RESULTS AND DISCUSSION
Figure 1 shows a typical total ion current (TIC) chromatogram
of a 250 ng/g MMS. The TIC chromatogram is a summation of
the ion signal generated by all the precursor f fragment ion
transitions in a designated acquisition window. Seven separate data
acquisition windows were used, and each is delineated by vertical
bars. The precursor f fragment ion transitions monitored for an
analyte constituted a separate experiment within a particular
window. If an acquisition window contained multiple experiments
(i.e., analytes), the experiments were continuously concatenated
for the duration of that window. During the course of these
experiments (2 months), we would observe slight shifts in
analyte elution time, which required adjustment of an acquisition
window.
Compound Stability of â-Lactams in Methanol/Water.
Tyczkowska et al. previously reported degradation of CLOX in
100 ppm stock solutions stored at -20 °C over a period of 8 weeks
using a variety of solvents.22 In that study, they reported complete
degradation of CLOX in 50:50 methanol/water in two weeks. Table
4 shows the relative MRM TIC (%) of each analyte in the third
recovery study (as measured in MMS) compared to the MRM
TIC of each analyte in the second recovery study (also measured
in MMS). The same stock solutions were used in the second and
third recovery studies, which were prepared 2 days prior to their
use in the second recovery study. An interval of 12 days elapsed
between the second and third recovery studies, and during that
interval, stock solutions were stored in -20 °C freezer in 50:50
methanol/water. Instrument parameters for the second and third
(22) Tyczkowska, K. L.; Voyksner, R. D.; Aronson, A. L. J. Chromatogr. 1992,
594, 195-201.
Table 4. Relative MRM TIC (%) of Each Analyte (As
Measured in MMS) of the Third Recovery Study
Compared to the MRM TIC of Each Analyte in the
Second Recovery Study (Also Measured in MMS)a
analyte 1 ng/g 10 ng/g 100 ng/g 1000 ng/g av ( SD
DECEPH 95 ( 10 93 ( 5 89 ( 11 92 ( 5
AMOX 91 ( 7 93 ( 1 101 ( 2 110 ( 3 99 ( 2
DCCD 80 ( 4 103 ( 2 104 ( 2 117 ( 2 101 ( 1
AMP 100 ( 1 98 ( 0 103 ( 1 105 ( 1 101 ( 1
CFZN 92 ( 1 97 ( 1 96 ( 0 95 ( 1 95 ( 1
PEN G 93 ( 1 99 ( 2 109 ( 0 104 ( 1 101 ( 1
PEN V 93 ( 6
(250 ng/g)
OXA 88 ( 3 90 ( 3 103 ( 4 100 ( 2 95 ( 2
CLOX 71 ( 5 79 ( 1 88 ( 4 92 ( 2 82 ( 2
NAF 95 ( 4 93 ( 1 101 ( 0 100 ( 1 97 ( 1
DICLOX 93 ( 15 81 ( 5 88 ( 2 94 ( 1 89 ( 4
a The same stock solutions were used in preparing MMS and
fortified samples for the second and third recovery studies. Twelve
days elapsed between the second and third recovery studies. During
that interval, stock solutions were stored in -20 °C freezer in 50:50
methanol/water. Instrument parameters were identical for both studies.
Figure 2. Top panel: MMS calibration curve for PEN G normalized
with respect to the internal standard (PEN V). Inset shows the
confirmatory ion ratio of the intensities of the two precursor f
fragment ion transitions as a function of concentration. Bottom
panel: MMS calibration curve for NAF normalized with respect to
the internal standard (PEN V). Inset shows the confirmatory ion ratio
of the intensities of the two precursor f fragment ion transitions as
a function of concentration.
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recovery studies were identical. As shown in Table 4, we did not
observe any significant decline in analyte ion signal in the MMS
for the third recovery study compared to the MMS for the second
recovery study, except perhaps for a 20% decline for CLOX and
10% decline for DICLOX. Confirmation data for analyte identifica-
tion for the second and third recovery studies are shown in the
middle and bottom panel of Table 6, respectively.
Calibration Curves of Matrix-Matched Standards. Figure
2 (top panel) shows a typical MMS calibration curve of PEN G.
The best fit of the MMS was obtained with a second-order
polynomial function generated using a nonlinear curve-fitting
function of the graphing software. As shown, the summation of
the integrated areas of the two transitions of PEN G, i.e., I335f160
+ I335f176, were normalized with respect to the summation of
integrated areas of the two transitions of the internal standard
PEN V (I351f160 + I351f192). The data were also given a 1/x
weighting. An inset in Figure 2 (top panel) shows the ratio of the
two transitions of PEN G as a function of concentration. I335f176/
I335f160 remains relatively constant as a function of concentration
except at very low concentrations. Figure 2 (bottom panel) shows
a typical MMS calibration curve for NAF which shows the most
pronounced nonlinearity observed in MMS calibration curves for
any of the analytes in this study. Two transitions were monitored
for NAF: m/z 415 f 256 and m/z 415 f 199. The inset of Figure
2 (bottom panel) shows the confirmation ratio I415f256/I415f199 as
a function of concentration. The ratio of the two transitions
(I415f256/I415f199) shows an increase, albeit within a narrow range,
in the confirmation ratio as a function of concentration. The origin
of this change is likely due to detector nonlinearity. The API 3000
uses a horn-shaped channel electron multiplier (CEM) for ion
detection. Ions exiting the third quadrupole are deflected directly
into the horn of the detector striking its surface and initiating a
cascade of electrons. CEM detectors have an S-shaped response
curve. In consequence, the number of ions that strike the detector
corresponds linearly to the amount of current generated from the
detector within a limited range. At the high end of the response
curve, the current generated from the detector under-represents
the actual number of ions striking the detector because of
saturation of its elements during the electron cascade. It is possible
that the increase in I415f256/I415f199 as a function of concentration
is due to detector saturation by I415f199 whereas I415f256, whose
signal intensity is eight times less intense than I415f199, does not
saturate the detector or saturates it to a lesser extent. In other
words, I415f256 and I415f199 are on different regions of the detector
response curve, and thus, the confirmation ratio increases as a
function of concentration. As shown in Figure 1, the ionization
efficiency of NAF is relatively high among the antibiotics in the
present study, and this high ionization efficiency would also
contribute to detector saturation by its most abundant transition,
i.e., m/z 415 f 199. AMP also possesses a high ionization
efficiency, and one might expect to observe a similar detector
saturation. This was indeed found to be the case.
It is possible, of course, to eliminate detector saturation by
simply reducing the detector gain by lowering the voltage across
the detector. However, developing multiresidue methods that use
mass spectrometric detection often requires adjusting instrument
parameters to compromise settings that are adequate for the
monitoring of all analytes but not necessarily optimal for each
analyte at every concentration. Lowering the detector gain to avoid
saturation of the most abundant transition of an analyte that has
the highest ionization efficiency may result in a loss of detection
sensitivity for the least abundant transition of an analyte that has
the lowest ionization efficiency. The MMS used in the present
study covered a 3 orders-of-magnitude concentration range.
Normally, it is only necessary for standards to cover a concentra-
tion range of 1/2X, X, and 2X (where X is the tolerance or
maximum residue limit of the analyte). However, in the present
multiresidue study, the established tolerances of the analytes
ranged as follows: 10, 50, 100, and 8000 ng/g. In addition, several
of the analytes in the present study do not have established
tolerances, and thus detection of these analytes at any concentra-
tion is violative. Thus, a wide MMS concentration range was
necessary. Finally, nonlinear calibration curves do not invalidate
their use in the calculation of concentrations of known (fortified)
or unknown (incurred) samples as long as the interpolation of
nonlinear curves is sufficiently accurate. The correlation coef-
ficients (R2) of the calibration curves used in recovery studies and
analysis of incurred samples are summarized in Table 5. Best fit
was obtained using a 1/x weighted second-order polynomial for
most calibration curves.
Confirmation and Quantitation of Fortified Samples. Table
6 summarizes the confirmatory analysis of fortified samples in
three recovery studies. Stock solutions used in preparing fortified
and MMS samples were 7 days old at the time of the first recovery
Table 5. Correlation Coefficients (R2) of Calibration Curves of Matrix-Matched Standards Used in Recovery Studies
(Rec) and Analysis of 30 Incurred Samples (Inc)a
analyte first Rec
Inc 11-13
and 17-18
Inc 14-16
and 19-20
Inc 1-6
and 8-10 Inc 21-30 Inc 7
second
Rec
third
Rec
DECEPH 0.96765 0.992 63 0.993 00 0.999 42 0.992 25 0.990 76
AMOX 0.99276 0.998 47 0.997 37
DCCD 0.99937 0.998 31 0.998 01 0.996 57 0.998 92 0.997 65 0.999 28
AMP 0.99943 0.999 82 0.999 82 0.999 16 0.999 66
CFZN 0.99945 0.999 48 0.999 52
PEN G 0.99972 0.999 51 0.999 55 0.999 87 0.999 42 0.999 48 0.999 71
OXA 0.99972 0.999 75 0.999 85
CLOX 0.99970 0.999 57 0.999 67
NAF 0.99917 0.999 92 0.999 65
DICLOX 0.99925 0.999 59 0.999 81
a Best fit was obtained using a 1/x weighted second-order polynomial for most calibration curves. Analyses performed on separate days in
chronological order left-to-right over a period of 2 months.
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study (top panel), 2 days old at the time of the second recovery
study (middle panel), and 14 days old at the time of the third
recovery study (bottom panel). The same stock solutions were
used in the second and third recovery studies. Table 6 compares
the ratio of the intensities of the two most abundant transitions
of each antibiotic, at its established tolerance, in fortified samples
and MMS for each of the three recovery studies. For analytes
that do not have an established tolerance level, a confirmation
ratio at 10 ng/g is reported. Table 6 shows that the confirmation
ratios of the fortified samples are within 20% of the confirmation
ratio of the MMS and thus within the guidelines of confirmation
for chemical residue analysis.23-26 Table 6 also includes the
retention time (tR) of each analyte in MMS and fortified samples
that are found to be essentially identical within instrumental
variation.
Table 7 shows the average recoveries (%) and their associated
standard deviations for each of the antibiotics in fortified samples.
Fortification experiments were replicated on three separate days
(23) Li, L. Y. T.; Campbell, D. A.; Bennett, P. K.; Henion, J. Anal. Chem. 1996,
68, 3397-3404.
(24) Sphon, J. A. J. Assoc. Off. Anal. Chem. 1978, 61, 1247-1253.
(25) Bethem, R.; Boison, J.; Gale, J.; Heller, D.; Lehotay, S. J.; Loo, J.; Musser,
S.; Price, P.; Stein S. J. Am. Soc. Mass Spectrom. 2003, 14, 528-541.
(26) Andre´, F.; De Wasch, K.; De Brabander, H. F.; Impens, S. R.; Stolker, L. A.
M.; van Ginkel, L.; Stephany, R. W.; Schilt, R.; Courtheyn, D.; Bonnaire, Y.;
Fu¨rst, P.; Gowik, P.; Kennedy, G.; Kuhn, T.; Moretain, J,-P. Trends Anal.
Chem. 2001, 20, 435-445.
Table 7. Average (%) and Standard Deviation of
Recoveries of 10 â-Lactams in Fortified Control Tissue
at 5, 10, 25, 50, 100, 250, 500, and 1000 ng/g Using
Dispersive-SPE Cleanup and LC/MS/MS Analysisa
analyte first Rec second Rec third Rec av ( SD
RSD
(%)
DECEPH 79.0 ( 17.2 69.4 ( 6.4 67.5 ( 8.1 72.0 ( 12.4 17.2
AMOX 75.6 ( 7.5 63.9 ( 3.3 71.1 ( 7.8 70.0 ( 8.0 11
DCCD 56.4 ( 5.2 56.9 ( 4.7 61.3 ( 7.1 58.2 ( 6.0 10
AMP 75.1 ( 4.1 68.9 ( 3.1 70.5 ( 4.9 71.5 ( 4.8 6.7
CFZN 80.9 ( 3.6 70.3 ( 2.5 74.5 ( 4.4 75.2 ( 5.7 7.6
PEN G 78.9 ( 3.8 71.5 ( 3.9 73.0 ( 4.7 74.5 ( 5.2 7.0
OXA 79.8 ( 3.5 72.3 ( 2.2 72.9 ( 3.7 75.0 ( 4.6 6.1
CLOX 79.5 ( 3.9 72.1 ( 2.9 73.7 ( 4.2 75.1 ( 4.9 6.5
NAF 78.5 ( 4.5 69.3 ( 1.7 70.8 ( 5.5 72.9 ( 5.8 8.0
DICLOX 79.8 ( 3.8 65.0 ( 3.0 69.4 ( 5.2 71.4 ( 7.4 10
a Fortification experiments replicated on three separate days (n )
24). Stock solutions were 7 days old at the time of the first recovery
study, 2 days old at the time of the second recovery study, and 14
days old at the time of the third recovery study.
Table 6. Confirmatory Analysis of Fortified Samples in Three Recovery Studiesa
fortified matrix-matched std
analyte
tolerance
level (ng/g)
fortified
concn (ng/g)
fragment
ions ion ratio tR (min) ion ratio tR (min)
First Recovery Study
DECEPH 100b 100 292/152 0.859 ( 0.024 9.84 0.851 ( 0.049 9.86
AMOX 10 10 114/349 0.446 ( 0.049 10.49 0.423 ( 0.003 10.51
DCCD 8000c 1000 397/241 0.492 ( 0.003 12.20 0.495 ( 0.002 12.20
AMP 10 10 192/106 0.266 ( 0.004 13.01 0.271 ( 0.002 13.02
CFZN d 10 156/323 0.364 ( 0.003 15.96 0.360 ( 0.008 15.98
PEN G 50 50 176/160 0.804 ( 0.006 20.09 0.803 ( 0.001 20.11
PEN V d 500 192/160 0.065 ( 0.001 21.09 0.065 ( 0.001 21.09
OXA d 10 243/160 0.744 ( 0.001 21.40 0.751 ( 0.013 21.41
CLOX 10 10 277/160 0.949 ( 0.009 21.94 0.919 ( 0.010 21.96
NAF d 10 256/199 0.121 ( 0.003 22.26 0.120 ( 0.003 22.27
DICLOX d 10 311/160 0.522 ( 0.051 22.52 0.497 ( 0.007 22.53
Second Recovery Study
DECEPH 100b 100 292/152 0.793 ( 0.006 10.75 0.804 ( 0.017 10.76
AMOX 10 10 114/349 0.388 ( 0.001 11.32 0.405 ( 0.005 11.32
DCCD 8000c 1000 397/241 0.482 ( 0.016 13.07 0.484 ( 0.002 13.02
AMP 10 10 192/106 0.326 ( 0.007 13.82 0.326 ( 0.002 13.83
CFZN d 10 156/323 0.332 ( 0.009 16.62 0.341 ( 0.001 16.61
PEN G 50 50 176/160 0.784 ( 0.001 20.59 0.788 ( 0.004 20.61
PEN V d 250 192/160 0.065 ( 0.001 21.57 0.065 ( 0.001 21.58
OXA d 10 243/160 0.907 ( 0.013 21.81 0.894 ( 0.015 21.80
CLOX 10 10 277/160 1.095 ( 0.068 22.24 1.080 ( 0.018 22.25
NAF d 10 256/199 0.106 ( 0.001 22.48 0.106 ( 0.002 22.48
DICLOX d 10 311/160 0.632 ( 0.074 22.71 0.668 ( 0.044 22.70
Third Recovery Study
DECEPH 100b 100 292/152 0.865 ( 0.005 10.85 0.881 ( 0.009 10.90
AMOX 10 10 114/349 0.374 ( 0.008 11.48 0.411 ( 0.009 11.49
DCCD 8000c 1000 397/241 0.470 ( 0.001 13.12 0.472 ( 0.002 13.09
AMP 10 10 192/106 0.309 ( 0.003 13.96 0.314 ( 0.005 13.98
CFZN d 10 156/323 0.336 ( 0.015 16.77 0.325 ( 0.004 16.79
PEN G 50 50 176/160 0.804 ( 0.001 20.70 0.806 ( 0.003 20.71
PEN V d 250 192/160 0.068 ( 0.000 21.66 0.067 ( 0.000 21.64
OXA d 10 243/160 0.913 ( 0.015 21.92 0.911 ( 0.008 21.92
CLOX 10 10 277/160 1.059 ( 0.092 22.31 1.056 ( 0.004 22.30
NAF d 10 256/199 0.106 ( 0.001 22.54 0.106 ( 0.003 22.54
DICLOX d 10 311/160 0.647 ( 0.030 22.76 0.647 ( 0.052 22.77
a Stock solutions used in preparing fortified and MMS samples were 7 days old at the time of the first recovery study, 2 days old at the time of
the second recovery study, and 14 days old at the time of the third recovery study. The same stock solutions were used in the second and third
recovery studies. b The tolerance for cephapirin + desacetylcephapirin is 100 ng/g. c The tolerance for total desfuroylceftiofur residues in beef
kidney tissue is 8000 ng/g. The described LC/MS/MS method detects only DCCD. d Tolerances not established for these analytes.
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at concentrations of 5, 10, 25, 50, 100, 250, 500, and 1000 ng/g to
test intraassay ruggedness of the method. No concentration effects
were observed; thus, the recoveries were averaged across the
entire concentration range (n ) 24). With the exception of DCCD,
analyte recoveries fell within 70-75% with relative standard
deviations (RSDs) of <12% (except for DECEPH, which had 17%
RSD). DCCD showed the lowest recovery at 58%, but a
reproducibility of 10% RSD over multiple days and a wide
concentration range demonstrates the consistency of the method.
Because DCCD has a reversible disulfide bond between DFC and
cysteine, its lower recovery is likely due to the DCCD disulfide
bond undergoing exchange with protein thiols or disulfide bonds
in the homogenized tissue resulting in the formation of a DFC-
protein disulfide complex and, thus, its subsequent loss during
the solvent extraction/deproteinization step or its nondetection
by conversion to a DFC-peptide disulfide complex not monitored
in the present study, e.g., desfuroylceftiofur glutathione di-
sulfide.19,27-30
Confirmation and Quantitation of Incurred Samples.
Thirty beef kidney samples suspected of containing violative levels
of antibiotics were previously analyzed by the Food Safety and
Inspection Service (Midwestern Laboratory, St. Louis, MO) using
their approved semiquantitative seven-plate microbial assay.31 The
microbial assay detects the presence of antibiotics by inhibition
of microbial growth on multiple plates. When a tissue extract is
deposited onto an agar plate, a circular zone of inhibition will form
around the spot where the extract was deposited if the extract
contains antimicrobial agents, such as caused by the presence of
(27) Jaglan, P. S.; Cox, B. L.; Arnold, T. S.; Kubrick, M. F.; Stuart, D. J.; Gilbertson,
T. J. J. Assoc. Off. Anal. Chem. 1990, 73, 26-30.
(28) Beconi-Barker, M. G.; Roof, R. D.; Millerioux, L.; Kausche, F. M.; Vidmar,
T. J.; Smith E. B.; Callahan, J. K.; Hubbard, V. L.; Smith, G. A.; Gilbertson,
T. J. J. Chromatogr., B 1995, 673, 231-244.
(29) Fagerquist, C. K.; Hudgins, R. R.; Emmett, M. R.; Håkansson, K.; Marshall,
A. G. J. Am. Soc. Mass Spectrom. 2003, 14, 302-310.
(30) Fagerquist, C. K. Rapid Commun. Mass Spectrom. 2004, 18, 685-700.
(31) Payne, M. A.; McBride, M. D.; Utterback, W. W.; Breitmeyer, R. E.; Alberg,
L.; Martin, D.; Cullor, J. J. Am. Vet. Med. Assoc. 1999, 214, 1048-1050.
Table 8. Quantitative LC/MS/MS Analysis and Semiquantitative Microbial Assay Analysis of 30 Incurred Bovine
Kidney Tissuesa
LC/MS/MS analysis 7-plate microbial assayincurred
sample
tSTD
(weeks) analyte(s) level (ng/g) evaluation level (ng/g)
1K 3.5 PEN G 86 ( 6 Pen(+) violative 110
2K 3.5 PEN G 40 ( 3 Pen(+) violative 70
DECEPH 2.1 ( 0.4
3K 3.5 PEN G 114 ( 13 Pen(+) violative 140
4K 3.5 DECEPH 1671 ( 343 Pen(+) violative 120
5K 3.5 PEN G 338 ( 43 Pen(+) violative 530
DECEPH 202 ( 30
6K 3.5 PEN G 59 ( 6 Pen(+) violative 100
7K 4 DCCD 10 400 ( 1310 UMI (DCCD
suspected)
12.3
mm
8K 3.5 PEN G 107 ( 8 Pen(+) violative 110
9K 3.5 AMP 139 ( 11 Pen (+) violative
in kidney
570
Pen (+) in liver 70
Pen (+) in muscle 70
10K 3.5 PEN G 205 ( 17 Pen (+) violative 150
11K 2 PEN G 43 ( 3 Pen (+) violative 110
12K 2 PEN G 1037 ( 72 Pen (+) violative 1520
13K 2 PEN G 35 ( 3 Pen (+) violative 60
14K 3 PEN G 113 ( 9 Pen (+) violative 110
15K 3 AMP 69 ( 5 Pen (+) violative 310
16K 3 PEN G 15 ( 2 Pen (+) nonviolative 50
17K 2 PEN G 24 ( 3 Pen (+) violative 70
18K 2 PEN G 212 ( 15 Pen (+) violative 430
DCCD 112 ( 16
19K 3 PEN G 165 ( 16 Pen (+) violative 150
20K 3 PEN G 342 ( 26 Pen (+) violative 400
DECEPH 272 ( 49
21K 4 no analytes negative
22K 4 PEN G 48 ( 6 Pen (+) violative 230
DECEPH 3 ( 1
23K 4 PEN G 62 ( 9 Pen (+) violative 260
24K 4 PEN G 273 ( 23 Pen (+) violative. 460
DCCD 215 ( 25 also violative for
sulfamethazone
by ELISA
25K 4 DCCD 2250 ( 246 Pen (+) violative 70
26K 4 PEN G 64 ( 5 Pen (+) violative 190
27K 4 PEN G 73 ( 7 Pen (+) violative in kidney
UMI (DCCD suspected) in liver
120
DECEPH 15 ( 3
28K 4 PEN G 178 ( 13 Pen (+) violative 330
29K 4 PEN G 608 ( 58 Pen (+) violative 1150
30K 4 PEN G 77 ( 8 Pen (+) violative 190
a tSTD is the age (in weeks) of stock solutions used in preparing matrix-matched standards.
1480 Analytical Chemistry, Vol. 77, No. 5, March 1, 2005
an antibiotic. The diameter of the zone of inhibition (in mm)
reflects the amount or strength of the antibiotic present. To
correlate zone diameter to antibiotic concentration, a series of
dilution standards of PEN G were used to make a calibration
curve. PEN G has a tolerance of 50 ng/g. If an unknown sample
has a zone of inhibition diameter greater in size than that produced
by a 50 ng/g equivalent PEN G standard, then the sample is
considered Pen (+) violative. If the sample has a smaller zone of
inhibition, then the sample is considered Pen (+) nonviolative.
The PEN G calibration curve can also be used to assign a
“concentration” to an unknown sample. However, it should be
noted that such a concentration assignment does not constitute a
direct measurement of the concentration of the antibiotic but a
concentration with respect to the strength of the antimicrobial
activity of PEN G. The seven-plate microbial assay was also
designed to be able to distinguish between penicillins and
cephalosporins. DCCD, DECEPH, and CFZN are cephalosporins
whereas the other â-lactams in this study are penicillins. Detection
of a cephalosporin with the seven-plate assay should result in a
particular pattern referred to as a “penase” resistant pattern.
Penase is an abbreviation for penicillinase: an enzyme produced
by bacteria to inactivate penicillins. Cephalosporins are resistant
to inactivation by penicillinase and thus are referred to as penase
resistant. A sample producing a penase-resistant pattern with the
seven-plate assay is designated as an unknown microbial inhibitor
(or UMI).
After analysis by the microbial assay, the samples were
forwarded to our laboratory for analysis by LC/MS/MS without
prior knowledge of the results of the microbial assay. Once the
LC/MS/MS analysis was complete, the results of the two
analytical techniques were simultaneously exchanged between the
two laboratories. Table 8 summarizes the results of both sets of
analyses. The percent recoveries of analytes in fortified samples
were used to calculate the actual concentrations of analytes in
incurred samples. We found general agreement between the LC/
MS/MS analysis and the microbial assay for most of the 30
samples in that there was (1) analytical concurrence with respect
to identification of the antibiotic as either a penicillin or a
cephalosporin, (2) analytical concurrence with respect to the
sample containing violative versus nonviolative levels of an
antibiotic, and (3) analytical concurrence (within a factor of 2-
4) with respect to antibiotic concentration. Twenty-three samples
fell into this “general agreement” category. A few observations
should be made about those samples. First, LC/MS/MS analysis
nearly always measured an antibiotic concentration level that was
lower than that measured by the microbial assay. The most likely
Table 9. Confirmatory LC/MS/MS Analysis of Incurred Bovine Kidney Tissues Using Matrix-Matched Standardsa
incurred matrix-matched stdincurred
sample
analyte
detected
fragment
ions ion ratio tR (min) ion ratio tR (min)
tStd
(weeks)
1K PEN G 176/160 0.824 ( 0.002 20.2 0.821 ( 0.004 20.3 3.5
2K PEN G 176/160 0.830 ( 0.006 20.2 0.825 ( 0.009 20.2 3.5
DECEPH 112/152 0.957 ( 0.010 10.2 0.823 ( 0.006 10.1 3.5
3K PEN G 176/160 0.819 ( 0.004 20.2 0.814 ( 0.003 20.3 3.5
4K DECEPH 112/152 0.863 ( 0.007 10.2 0.870 ( 0.004 10.3 3.5
5K PEN G 176/160 0.819 ( 0.001 20.2 0.821 ( 0.001 20.3 3.5
DCCD 397/241 0.456 ( 0.001 12.5 0.446 ( 0.003 12.6 3.5
6K PEN G 176/160 0.816 ( 0.002 20.3 0.821 ( 0.004 20.3 3.5
7K DCCD 397/241 0.435 ( 0.001 13.0 0.434 ( 0.001 12.9 4
8K PEN G 176/160 0.821 ( 0.003 20.3 0.814 ( 0.003 20.3 3.5
9K AMP 192/106 0.323 ( 0.000 13.4 0.316 ( 0.000 13.4 3.5
10K PEN G 176/160 0.816 ( 0.003 20.3 0.814 ( 0.003 20.3 3.5
11K PEN G 176/160 0.814 ( 0.007 20.1 0.814 ( 0.011 20.1 2
12K PEN G 176/160 0.833 ( 0.005 20.1 0.817 ( 0.002 20.1 2
13K PEN G 176/160 0.827 ( 0.002 20.1 0.814 ( 0.011 20.1 2
14K PEN G 176/160 0.821 ( 0.000 20.2 0.812 ( 0.004 20.2 3
15K AMP 192/106 0.318 ( 0.004 13.3 0.319 ( 0.003 13.3 3
16K PEN G 176/160 0.820 ( 0.001 20.2 0.845 ( 0.003 20.1 3
17K PEN G 176/160 0.832 ( 0.001 20.1 0.814 ( 0.011 20.1 2
18K PEN G 176/160 0.819 ( 0.009 20.1 0.819 ( 0.002 20.1 2
DCCD 397/241 0.464 ( 0.001 12.3 0.463 ( 0.001 12.3 2
19K PEN G 176/160 0.822 ( 0.001 20.2 0.812 ( 0.004 20.2 3
20K PEN G 176/160 0.814 ( 0.004 20.2 0.808 ( 0.003 20.2 3
DECEPH 112/152 0.857 ( 0.007 10.2 0.842 ( 0.007 10.1
21K no analytes
22K PEN G 176/160 0.801 ( 0.002 20.4 0.802 ( 0.003 20.4 4
DECEPH 112/152 0.779 ( 0.164 10.5 2.678 ( 0.642 10.4 4
23K PEN G 176/160 0.805 ( 0.000 20.4 0.802 ( 0.003 20.4 4
24K PEN G 176/160 0.795 ( 0.000 20.4 0.802 ( 0.003 20.4 4
DCCD 397/241 0.445 ( 0.000 12.7 0.442 ( 0.001 12.7 4
25K DCCD 397/241 0.440 ( 0.006 12.8 0.443 ( 0.002 12.7 4
26K PEN G 176/160 0.796 ( 0.002 20.4 0.802 ( 0.003 20.4 4
27K PEN G 176/160 0.800 ( 0.003 20.4 0.802 ( 0.003 20.4 4
DECEPH 112/152 0.881 ( 0.002 10.5 0.804 ( 0.030 10.4 4
28K PEN G 176/160 0.802 ( 0.002 20.4 0.801 ( 0.005 20.4 4
29K PEN G 176/160 0.806 ( 0.001 20.4 0.808 ( 0.001 20.4 4
30K PEN G 176/160 0.804 ( 0.001 20.5 0.802 ( 0.003 20.4 4
a tR is the retention time of the analyte. tStd is the age (in weeks) of stock solutions used in preparing matrix-matches standards.
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reason for this discrepancy was analyte degradation in the sample
during the interval between the microbial assay and LC/MS/MS
analysis (which were months apart). Analyte degradation in the
unhomogenized kidney sample might also explain the analytical
dissonance of samples 2K, 11K, 13K, 17K, and 22K that did not
fall within the general agreement category because the LC/MS/
MS analysis indicates a nonviolative level of PEN G whereas the
microbial assay indicates a Pen (+) violative level of antibiotic.
Second, in contrast with LC/MS/MS analysis, the microbial assay
cannot specifically identify which antibiotic is present. However,
it is interesting to note that the microbial assay does appear to
give an approximate estimate of an antibiotic’s strength. For
instance, the microbial assay of samples 9K and 15K indicates a
Pen (+) antibiotic concentration level that is 4-5 times higher
than that estimated by LC/MS/MS analysis. LC/MS/MS specif-
ically identifies the antibiotic as AMP as well as quantifying its
concentration. AMP is a more powerful antibiotic than PEN G,
which is consistent with it having an approved tolerance of 10
ng/g whereas PEN G has a tolerance of 50 ng/g. Third, in samples
2K, 5K, 18K, 20K, 22K, 24K, and 27K, the presence of a penicillin
in a sample (specifically PEN G) appears to mask the presence
of the second antibiotic in the microbial assay, specifically a
cephalosporin. In contrast, LC/MS/MS analysis not only is able
to confirm the presence of these “secondary” antibiotics, it also
quantifies the actual amounts of each.
The most serious discrepancy between the microbial assay and
the LC/MS/MS analysis occurs for samples 4K and 25K. The
microbial assay indicates both samples as Pen (+) violative;
however, LC/MS/MS indicates a violative level DECEPH in 4K
and a possibly violative level of desfuroylceftiofur residues in 25K.
DECEPH and DCCD are cephalosporins, not penicillins. The
analysis of these two samples is perplexing because the seven-
plate microbial assay was designed to distinguish between
penicillins and cephalosporins. For example, the microbial assay
identifies sample 7K as a UMI (DCCD suspected) with a relatively
large zone of inhibition (12.3 mm). LC/MS/MS analysis indicates
sample 7K as having a violative level of DCCD. Thus, the results
of the two analyses are completely concurrent for sample 7K, and
yet for samples 4K and 25K, the results of the two analyses are
anomalously dissonant.
Table 9 summarizes the confirmatory analysis of the 30
incurred tissue samples. The MMS that was nearest in concentra-
tion to the incurred sample are listed. The confirmatory ion ratios
of analytes in incurred samples were within 20% of the ion ratios
of analytes in MMS.23-26 In addition, the tR of analytes in incurred
samples are identical, within instrumental variation, to the tR of
analytes in MMS.
Finally, an interesting factor in our quantitative measurements
was that the internal standard (PEN V) gave an ion signal intensity
that was 10-20% higher in incurred tissue extracts than in control
tissue extracts even though identical amounts of the standard were
added to both. The reason for this difference is not certain, but
ion suppression effects could be to blame. Furthermore, differ-
ences in tissue degradation may have occurred resulting in
differences in the contaminant composition of tissue extracts,
which may have led to differences in ionization efficiency of the
internal standard. This observation notwithstanding, the signal
intensities of all analytes were normalized with respect to the
signal intensity of the internal standard.
CONCLUSIONS
We have presented a multiresidue method for the confirmation
and quantitation of 10 â-lactam antibiotics in bovine kidney tissue.
The method involves simple solvent extraction/deproteinization,
dispersive-SPE cleanup, and LC/MS/MS analysis. In contrast to
conventional SPE cleanup, dispersive-SPE allowed tripling (or
quadrupling) the number of samples prepared in a single day.
The method is simple, rapid, rugged, sensitive, and highly specific
with recoveries of 70% (or better) for all the analytes except DCCD
for which a recovery of 58% was obtained. Confirmation and
quantitation were achieved at concentrations below tolerance
levels for all antibiotics that had an approved tolerance and at 10
ng/g for those antibiotics that did not have an approved tolerance.
When tested on incurred samples, the method was able to do the
following: (i) identify and quantify the antibiotic present in
samples that were penicillin (+) by the microbial assay; (ii) identify
and quantify the presence of cephalosporin residues in multiresi-
due samples that were not detected using the microbial assay;
and (iii) confirm and quantify only violative levels of cephalosporin
residue in samples the microbial assay identified as penicillin (+)
violative.
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